United States Surgical Robots Market By Component (Systems, Instruments & Accessories, Services) By Mechanism of Control (Computer Control v/s Direct Tele manipulator) By Application (Urologic Surgery, Orthopedic Surgery, General Surgery, Gynecology, Others), By End User (Hospitals & Clinics v/s Ambulatory Surgical Centers), By Region, Competition, Forecast & Opportunities, 2018-2028F

United States Surgical Robots Market is expected to show a robust growth during the forecast period on account of the growing demand for minimally invasive surgical procedures. Surgical robots have been coming up as the boon for surgeons or at multispecialty hospitals where for carrying out the complex procedure related to brain, heart and other delicate organs require high precision. These surgical robots are extremely helpful in cases where the healthcare facility is lacking the capabilities to carry out the surgery because of the staff shortage, thus use of surgical robots enables surgeons to work with the maximum stability and improved movements when working on delicate parts of the body to limit harm to healthy tissues. Additionally, use of surgical robots while performing a surgery prevents any unwanted incision along with saving a lot of time. This is achieved under the presence of qualified surgeons and under their supervision, the surgical robots are employed to carry out computer-assisted procedures. This has in turn caused the use of surgical robot largely in the United States. Through the production of highly effective surgical robots, the requirement for zero or the smallest possible margin of error has paved the way for advancements and generated a possibility for growth of the United States surgical robots market.

Robots are in high demand due to precision and accuracy in performing critical surgeries and minimizes the chances of human error is fueling the demand for surgical robots market. The United States already has a developed healthcare infrastructure and invests high amount for continuous technological advancements in healthcare sector.

The US Food and Drug Administration (FDA) gave Intuitive Surgical permission to use its Ion endoluminal device for minimally invasive biopsy in the peripheral lung in February 2019. The tool assisted surgeons in performing minimally invasive biopsies inside the lung's inner layers.

Increasing Use of Surgical Robots in Treatment of Cancer

American Cancer Society estimated diagnosis of 1.9 million new cancer cases and 608,570 cancer deaths in the United States in 2021.

Minimally Invasive Robot-assisted Surgeries

The use of surgical robots has significantly increased in minimally invasive procedures on account of the fact that they offer higher accuracy and precision. By offering highly enhanced vision capabilities that use HD cameras to observe the microscopic structures, surgical robots give doctors a superior view of the operating room. Unlike humans, robots can spin their hands around a full 360 degrees and can reach the hard to access areas.

A grant of about USD 2 million was given to the Vanderbilt Institute for Surgery and Engineering (VISE) in April 2019 for the creation of a surgical robot in a minimally invasive setting.

Rising Regulatory Approvals for New Robotic Surgery Technologies

The Food and Drug Administration (FDA) gave Zimmer Biomet permission to use its newest device, the "Rosa One Brain Application," in 2019.

The FDA also granted 510(k) approval to Corindus Vascular Robotics, Inc. in 2018 which is a pioneer in the development of precision vascular robotics for the use of its CorPath GRX System in peripheral vascular procedures.

The launch of new techniques or software in surgical robots and increasing adoption of these robots by the patients to go under the knife will increase the growth of the market in the upcoming years.

Technological Advancements

The market for surgical robots in the United States is expected to grow over the coming years as a result of technological developments. Examples include the integration of cameras, high-definition 3D imaging, computing technology, sensors, remote navigation technology systems, robotic controlled catheters, and other accessories used in surgical procedures. While certain surgical robots are used in the United States, the robot from Virtual Incision will travel beyond the country.

The MIRA platform from Virtual Incision will be utilized in a technology demonstration aboard the International Space Station which is granted by NASA. NASA's 2024 technology demonstration mission will make use of the miniaturized robotic-associated surgery (RAS) platform developed by the Lincoln, Nebraska-based company.

The platform obtained clearance for an IDE supplement in April 2021 after winning IDE approval in October 2020. A USD46 million Series C financing round was completed by the business last year to support the surgical robot platform.

Monteris Medical, a company based

Brain lesions or undesirable tissue can be destroyed using NeuroBlate's MRI-guided laser technology. Epilepsy, gliomas, brain metastases, and radiation necrosis are among the ailments that NeuroBlate has been used to treat in patients. Monteris Medical received FDA clearance of its NeuroBlate Fusion-S Software and released the product commercially in 2020.

The first and only FDA-approved surgical robot with minuscule humanoid-shaped arms with shoulder, elbow, and wrist joints that offers high dexterity was designed by Momentis Surgical, formerly known as Memic Innovative Surgery. The company’s Anovo system, previously called “Hominis,” is used for robotic-assisted transvaginal benign surgical operations in benign hysterectomy, salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal.

By implementing innovative and advanced technologies for the development of various surgical robots specializing to perform specific surgery to carry out different type of organ surgeries with improved outcomes for patients is expected to drive the market growth in the country.

Market Segmentation

United States surgical robots market is segmented into component, mechanism of control, application, end user, regional distribution, and company. Based on the Component, the market is divided into Systems, Instruments & Accessories, Services. Based on the Mechanism of Control, the market is divided between

Market Players

In 2019, the Johnson & Johnson subsidiary Ethicon purchased the robotic technology platform developer Auris Health. The goal of this acquisition is to boost the development of Ethion's digital surgical portfolio in order to fight lung cancer. In addition, OrthoSpace, Ltd. was acquired by Stryker Corporation in 2019;